Lantern Pharma Inc.

Q2 2025 13F Holders

Symbol
LTRN
CUSIP
51654W101
Type
Equity
Class
COM
Num filings
37
Total reported value, excl. options
$7.11 M
Manager Report Date Value ($000) Shares Option Type